Top Markets
Coin of the day
AVAX Technologies, Inc. AVAX Technologies, Inc.

AVAX Technologies, Inc.

AVXT
Clasificación en acciones #41955
AVAX Technologies, Inc. is an emerging biopharmaceutical company focused on... AVAX Technologies, Inc. is an emerging biopharmaceutical company focused on pioneering autologous cell vaccine methods for cancer therapy. Its pipeline includes lead candidates M-VAX, for melanoma, and O-VAX, targeting ovarian cancer, both of which have successfully concluded Phase II clinical trials. The firm is also developing LungVax, a potential treatment for non-small cell lung cancer. Established in 1990, the Philadelphia, Pennsylvania-based entity initially operated as Walden Laboratories, Inc. before adopting its current name, AVAX Technologies, Inc., in March 1996.
Precio por acción
$0.00001
Última sincronización: 2025-12-30
Capitalización bursátil
$6.89K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio AVAX Technologies, Inc. (AVXT)

Categoría

Ratio P/B de AVAX Technologies, Inc. (AVXT)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de AVAX Technologies, Inc., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de AVAX Technologies, Inc. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
6.2613 -
US
6.3483 -
NL
- -
CH
- -
KR
3.634 -
BE